Medical Properties Trust stock
MPTNYSEMedical Properties Trust, Inc., Real EstateISIN US58463J3041
40Score 40 out of 100, Weak
Price and trend
24 / 100
Price history
−65% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 60% below it.
Since May 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Sharply down: the price has fallen very quickly lately (RSI 13).
The price is 70% below its 52-week high. Largest decline in 20 years: 93% (February 2020 to November 2026).
Chart figures for advanced users
- SMA 50$3.07
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$4.43
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)13
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$1.78
- The lowest closing price of the last twelve months.
- Resistance$6.02
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Medical Properties Trust, Inc. belongs to the REIT (Healthcare Facilities) industry (United States) and, with a market value of $1.06B, is number 14 of 18 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $972.02M (down 2.4% year on year) and a loss of $277.05M.
- MEQIRI Score 40 out of 100 (Weak): rank 296 of 327 in Real Estate, median 55.
Show more
- The P/E is 4.3 (REIT (Healthcare Facilities) median 14.5, own median of recent years 16.8).
- For real estate investment trusts (REITs) what counts is funds from operations (FFO and AFFO). The P/E and the payout ratio of earnings say little here, because depreciation on properties depresses earnings.
- Our model puts fair value at $4.61, with the price 61% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Modestly valuedP/E 4.3, REIT (Healthcare Facilities) median 14.5, own median 16.8.Valuation 99
- High marginNet margin 24.1% over the last 12 months, REIT (Healthcare Facilities) median 6.6%.Profitability 62
- Earnings turn into cashFree cash flow 100% of earnings over the last 12 months.Fundamentals 51
Weaknesses
- Interest barely coveredOperating profit covers interest only 0.5 times.Stability 38
- Dividend at riskDividend yield 20.2%. At yields this high (15% or more), the dividend was cut by at least a fifth within a year in 69 of 100 cases from 2011 to 2025, against 7 of 100 at 2 to 4%.Capital allocation 24
- Share price fell sharplyDown 64% over the last 12 months.Momentum 12
Its standout strength is valuation, while growth and momentum hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- price far below its 52-week high
- high price swings
- weak momentum
What lowers it
- price not overheated over the past year
- low growth grade (crashed less often in the backtest)
Valuation
Valuation signal
Possible value trapIn our model the price counts as cheap below $3.29 and expensive above $7.68 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $3.18 (cash-flow model) and $6.03 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 12.8%. At 13.8% the fair value would be $4.45, at 11.8% it would be $4.80.
Possible value trap: looks cheap, but score below 50, high risk, weak growth.
Valuation metrics
Half from the cash-flow model, half from operating cash flow per share times the median price to cash flow of the REIT industry (14.5). For the fair value, FFO only counts when it is in line with operating cash flow. That is not the case here, for example because the REIT carries its properties at market value, records little depreciation or a gain on sale sits in earnings. The cash-flow model uses AFFO: operating cash flow less maintenance, estimated at 4% of revenue. New construction and acquisitions do not count as running costs there.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 10.1% on the twelve months before. Revenue has grown strongly since 2006, at around 17% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 96%, operating 56%, net −29%. Last 12 months: net 24%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 18 Feb 2027in 98 days
- Last reported
- 29 Oct 2026EPS reported $0.34 (expected −$0.01)above expectations
Analyst estimates
- Earnings per share
- $0.11+171.5%
- Revenue
- $981.8M−3.7%
- Earnings per share
- −$0.06−385.7%
- Revenue
- $988.1M−6.2%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −18.2%MPT reaffirms expected portfolio cash rents above $1 billion for 2027 and confirms its plan to refinance upcoming maturities, without changing guidance.
“For 2027, despite these sales, we continue to expect portfolio cash rents above $1 billion.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Oct 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
One insider bought on the open market in the last 6 months, $9,545 in total.
- Hanna James KevinPurchase
20 Aug 2026, Senior VP, Controller & CAO
- Shares
- 2,300
- Price
- $4.15
- Value
- $9,545
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Medical Properties Trust
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
327 rated companies in Real Estate
- This company
- 40
- Sector median
- 55
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in REIT (Healthcare Facilities)
The next larger and next smaller companies by market value
- National Health InvestorsNHI $3.24B61
- LTC PropertiesLTC $2.47B71
- Diversified Healthcare TrustDHC $1.78B32
- National Healthcare Properties, Inc. (NHP)NHP $1.14B41
- Care Property InvestCPINV.BR $603.96M65
- Universal Health Realty Income TrustUHT $542.5M61
- Community Healthcare TrustCHCT $431.38M56
- Chiron Real EstateXRN $357.26M46
ETFs that hold Medical Properties Trust
Held by 10 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares US Property Yield UCITS ETFIQQ7 | 0.08% | 0.40% | €554.91M |
| iShares Ageing Population UCITS ETF2B77 | 0.08% | 0.40% | €807M |
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.06% | 0.30% | €2.28B |
Show 5 more
| iShares Developed Markets Property Yield UCITS ETFIQQ6 | 0.05% | 0.59% | €812.71M |
| Amundi FTSE EPRA NAREIT Global UCITS ETF Dist10AJ | 0.05% | 0.24% | €603.52M |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.02% | 0.43% | €2.48B |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.01% | 0.35% | €8.19B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.01% | 0.35% | €434.1M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Aug 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.